{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:13:17Z","timestamp":1788307997790,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sublingual administration of nicotinamide mononucleotide (NMN) is hypothesized to enhance systemic bioavailability by bypassing hepatic first-pass metabolism, a significant limitation of oral intake. However, direct comparative evidence in humans has been lacking. This study aimed to compare the acute pharmacokinetics of NMN following single-dose oral and sublingual administration in a randomized, two-period crossover trial involving 14 healthy adult males. Participants received NMN via both routes, separated by an 8-day washout period. Blood samples were collected for 60\u00a0min post-administration to measure NMN and its metabolites, including nicotinamide (NAM), nicotinamide adenine dinucleotide (NAD\u207a), and the terminal catabolites N1-methyl-2-pyridone-5-carboxamide (2PY) and N1-methyl-4-pyridone-3-carboxamide (4PY). The incremental area under the curve (iAUC) was significantly higher for the terminal metabolites 2PY and 4PY following sublingual administration compared to the oral route. In contrast, no significant differences were found for the blood concentrations of NMN, NAM, or NAD\u207a between methods. Both administration routes were well-tolerated, with no adverse events reported. These findings provide the first direct evidence in humans that sublingual administration leads to a more rapid increase in the terminal metabolites (2PY and 4PY) over 0\u201360\u00a0min, although the metabolic origin of these increases could not be distinguished in the present study.<\/jats:p>","DOI":"10.1038\/s41598-026-57552-9","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:04:47Z","timestamp":1781600687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men"],"prefix":"10.1038","volume":"16","author":[{"given":"Jun","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-4127","authenticated-orcid":false,"given":"Masashi","family":"Morifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"57552_CR1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039 (2013).","journal-title":"Cell"},{"key":"57552_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.201708092","volume":"217","author":"D McHugh","year":"2018","unstructured":"McHugh, D. & Gil, J. Senescence and aging: Causes, consequences, and therapeutic avenues. J. Cell. Biol. 217, 65\u201377. https:\/\/doi.org\/10.1083\/jcb.201708092 (2018).","journal-title":"J. Cell. Biol."},{"key":"57552_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-022-00084-z","volume":"8","author":"M Igarashi","year":"2022","unstructured":"Igarashi, M. et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging 8, 5. https:\/\/doi.org\/10.1038\/s41514-022-00084-z (2022).","journal-title":"NPJ Aging"},{"key":"57552_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills, K. F. et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 24, 795\u2013806. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.013 (2016).","journal-title":"Cell Metab."},{"key":"57552_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud, L. et al. The NAD(+)\/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430\u2013441. https:\/\/doi.org\/10.1016\/j.cell.2013.06.016 (2013).","journal-title":"Cell"},{"key":"57552_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias, A. J., Perrone, R., Grozio, A. & Verdin, E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell. Biol. 22, 119\u2013141. https:\/\/doi.org\/10.1038\/s41580-020-00313-x (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"57552_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","volume":"25","author":"ME Migaud","year":"2024","unstructured":"Migaud, M. E., Ziegler, M. & Baur, J. A. Regulation of and challenges in targeting NAD(+) metabolism. Nat. Rev. Mol. Cell. Biol. 25, 822\u2013840. https:\/\/doi.org\/10.1038\/s41580-024-00752-w (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"57552_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127\u20131139. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.006 (2016).","journal-title":"Cell Metab."},{"key":"57552_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cmet.2019.05.015","volume":"30","author":"M Yoshida","year":"2019","unstructured":"Yoshida, M. et al. Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice. Cell Metab. 30, 329\u2013342. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.015 (2019).","journal-title":"Cell Metab."},{"key":"57552_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1210\/endrev\/bnad019","volume":"44","author":"S Bhasin","year":"2023","unstructured":"Bhasin, S., Seals, D., Migaud, M., Musi, N. & Baur, J. A. Nicotinamide adenine dinucleotide in aging biology: potential applications and many unknowns. Endocr. Rev. 44, 1047\u20131073. https:\/\/doi.org\/10.1210\/endrev\/bnad019 (2023).","journal-title":"Endocr. Rev."},{"key":"57552_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s0969-2126(00)00190-8","volume":"8","author":"I D\u2019Angelo","year":"2000","unstructured":"D\u2019Angelo, I. et al. Structure of nicotinamide mononucleotide adenylyltransferase: A key enzyme in NAD(+) biosynthesis. Structure 8, 993\u20131004. https:\/\/doi.org\/10.1016\/s0969-2126(00)00190-8 (2000).","journal-title":"Structure"},{"key":"57552_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536. https:\/\/doi.org\/10.1016\/j.cmet.2011.08.0144 (2011).","journal-title":"Cell Metab."},{"key":"57552_CR13","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1007\/s11357-024-01204-1","volume":"46","author":"M Morifuji","year":"2024","unstructured":"Morifuji, M., Higashi, S., Ebihara, S. & Nagata, M. Ingestion of beta-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. Geroscience 46, 4671\u20134688. https:\/\/doi.org\/10.1007\/s11357-024-01204-1 (2024).","journal-title":"Geroscience"},{"key":"57552_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040755","author":"M Kim","year":"2022","unstructured":"Kim, M. et al. Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: A randomized, double-blind placebo-controlled study. Nutrients https:\/\/doi.org\/10.3390\/nu14040755 (2022).","journal-title":"Nutrients"},{"key":"57552_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14060341","author":"C Benjamin","year":"2024","unstructured":"Benjamin, C. & Crews, R. Nicotinamide mononucleotide supplementation: Understanding metabolic variability and clinical implications. Metabolites https:\/\/doi.org\/10.3390\/metabo14060341 (2024).","journal-title":"Metabolites"},{"key":"57552_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","volume":"27","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab. 27, 1067\u20131080. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.018 (2018).","journal-title":"Cell Metab."},{"key":"57552_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081073","author":"S Bahraminejad","year":"2025","unstructured":"Bahraminejad, S. & Almoazen, H. Sublingual and buccal delivery: A historical and scientific prescriptive. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics17081073 (2025).","journal-title":"Pharmaceutics"},{"key":"57552_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114604","volume":"251","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Biomaterial-based drug delivery strategies for oral mucosa. Colloids Surf. B Biointerfaces 251, 114604. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114604 (2025).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"57552_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020148","author":"I Bacskay","year":"2025","unstructured":"Bacskay, I. et al. Bioavailability enhancement and formulation technologies of oral mucosal dosage forms: A review. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics17020148 (2025).","journal-title":"Pharmaceutics"},{"key":"57552_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311114","author":"AA Sauve","year":"2023","unstructured":"Sauve, A. A. et al. Triple-isotope tracing for pathway discernment of NMN-induced NAD(+) biosynthesis in whole mice. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241311114 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"57552_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2020.02.001","volume":"31","author":"I Shats","year":"2020","unstructured":"Shats, I. et al. Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway. Cell Metab. 31, 564\u2013579. https:\/\/doi.org\/10.1016\/j.cmet.2020.02.001 (2020).","journal-title":"Cell Metab."},{"key":"57552_CR22","doi-asserted-by":"publisher","first-page":"eadr1538","DOI":"10.1126\/sciadv.adr1538","volume":"11","author":"K Yaku","year":"2025","unstructured":"Yaku, K. et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation. Sci Adv 11, eadr1538. https:\/\/doi.org\/10.1126\/sciadv.adr1538 (2025).","journal-title":"Sci Adv"},{"key":"57552_CR23","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/1873-3468.14698","volume":"597","author":"LJ Kim","year":"2023","unstructured":"Kim, L. J. et al. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation. FEBS Lett. 597, 2196\u20132220. https:\/\/doi.org\/10.1002\/1873-3468.14698 (2023).","journal-title":"FEBS Lett."},{"key":"57552_CR24","doi-asserted-by":"publisher","first-page":"40365","DOI":"10.1074\/jbc.M111.275818","volume":"286","author":"L Galeazzi","year":"2011","unstructured":"Galeazzi, L. et al. Identification of nicotinamide mononucleotide deamidase of the bacterial pyridine nucleotide cycle reveals a novel broadly conserved amidohydrolase family. J. Biol. Chem. 286, 40365\u201340375. https:\/\/doi.org\/10.1074\/jbc.M111.275818 (2011).","journal-title":"J. Biol. Chem."},{"key":"57552_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42255-025-01421-8","volume":"8","author":"S Christen","year":"2026","unstructured":"Christen, S. et al. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans. Nat. Metab. 8, 62\u201373. https:\/\/doi.org\/10.1038\/s42255-025-01421-8 (2026).","journal-title":"Nat. Metab."},{"key":"57552_CR26","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.1038\/s41467-021-27080-3","volume":"12","author":"K Yaku","year":"2021","unstructured":"Yaku, K. et al. BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nat. Commun. 12, 6767. https:\/\/doi.org\/10.1038\/s41467-021-27080-3 (2021).","journal-title":"Nat. Commun."},{"key":"57552_CR27","doi-asserted-by":"publisher","first-page":"13103","DOI":"10.1038\/ncomms13103","volume":"7","author":"J Ratajczak","year":"2016","unstructured":"Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103. https:\/\/doi.org\/10.1038\/ncomms13103 (2016).","journal-title":"Nat. Commun."},{"key":"57552_CR28","doi-asserted-by":"publisher","first-page":"25938","DOI":"10.1074\/jbc.M113.470435","volume":"288","author":"A Grozio","year":"2013","unstructured":"Grozio, A. et al. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 288, 25938\u201325949. https:\/\/doi.org\/10.1074\/jbc.M113.470435 (2013).","journal-title":"J. Biol. Chem."},{"key":"57552_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102615","volume":"298","author":"A Kropotov","year":"2022","unstructured":"Kropotov, A. et al. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells. J. Biol. Chem. 298, 102615. https:\/\/doi.org\/10.1016\/j.jbc.2022.102615 (2022).","journal-title":"J. Biol. Chem."},{"key":"57552_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","volume":"67","author":"J Irie","year":"2020","unstructured":"Irie, J. et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr. J. 67, 153\u2013160. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0313 (2020).","journal-title":"Endocr. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57552-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:20:42Z","timestamp":1788304842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57552"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57552-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JW, SH, and MM are employees of Meiji Holdings Co., Ltd.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27464"}}